Jorge Luis Soriano

Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy.

Mayra Ramos, Patricia Lorenzo-Luaces, N González Lazo et al. · Cancer Biology & Therapy · 2012 · 68 citations · Full text

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

Silvio E. Perea, Idania Baladrón, Yanelda García et al. · Molecular and Cellular Biochemistry · 2011 · 43 citations

Molecular Pharmacology, Signal Transduction, Ck2 Phosphoaceptor Domain +12

Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast Cancer

Jorge Luis Soriano, Noyde Batista, Eduardo Santiesteban et al. · International Journal of Breast Cancer · 2011 · 38 citations · Full text

Semimechanistic model to characterize nonlinear pharmacokinetics of nimotuzumab in patients with advanced breast cancer

Leyanis Rodríguez‐Vera, Mayra Ramos, Eduardo Fernández‐Sánchez et al. · The Journal of Clinical Pharmacology · 2015 · 13 citations

Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas

Daniel F. Pilco‐Janeta, Myriam De la Cruz Puebla, Jorge Luis Soriano et al. · BMC Cancer · 2019 · 10 citations · Full text